RNAi Technology Market: Global Industry Growth, Trends, and Forecast
The RNAi Technology Market is witnessing strong growth as RNA interference technologies become increasingly important in therapeutic development, drug discovery, diagnostics, and biotechnology research. According to Market Research Future, the market was valued at USD 4.96 billion in 2024 and is projected to grow from approximately USD 5.49 billion in 2025 to USD 14.99 billion by 2035, registering a CAGR of 10.58%.
RNAi technology enables researchers to regulate gene expression by targeting specific RNA molecules. This capability has created opportunities for developing therapies for genetic disorders, metabolic diseases, cancer, and other complex conditions. Increasing investments in biotechnology research and growing demand for precision medicine are contributing to market expansion.
Small interfering RNA remains an important technology segment, while micro RNA is expected to experience significant growth. Therapeutics and drug discovery represent major application areas, supported by increasing pharmaceutical and biotechnology research activities.
North America currently holds a leading position in the market, while Asia-Pacific is expected to provide attractive growth opportunities because of expanding research infrastructure and increasing investment in biotechnology.
Overall, advances in RNA-based therapeutics, improved delivery systems, and growing research funding are expected to create significant opportunities for the global RNAi Technology Market through 2035.